Abstract
Oxazolidinone-quinolone hybrids, which combine the pharmacophores of a quinolone and an oxazolidinone, were synthesised and shown to be active against a variety of susceptible and resistant Gram-positive and Gram-negative bacteria. The nature of the spacer greatly influences the antibacterial activity by directing the mode of action, that is quinolone- and/or oxazolidinone-like activity. The best compounds in this series have a balanced dual mode of action and overcome all types of resistance, including resistance to quinolones and linezolid, in clinically relevant Gram-positive pathogens.
MeSH terms
-
Acetamides / pharmacology
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology*
-
DNA Topoisomerase IV / antagonists & inhibitors
-
Drug Resistance, Bacterial*
-
Gram-Negative Bacteria / drug effects*
-
Gram-Positive Bacteria / drug effects*
-
Linezolid
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Oxazolidinones / chemical synthesis
-
Oxazolidinones / chemistry
-
Oxazolidinones / pharmacology*
-
Quinolones / chemical synthesis
-
Quinolones / chemistry
-
Quinolones / pharmacology*
-
Structure-Activity Relationship
Substances
-
Acetamides
-
Anti-Bacterial Agents
-
Oxazolidinones
-
Quinolones
-
DNA Topoisomerase IV
-
Linezolid